|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 13 June 2007
doi: 10.1242/jcs.002345
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
2 Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
3 School of Life Sciences and Biotechnology, Korea University, Seoul, Korea
4 Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea
5 Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea
6 Genomine Research Division, Genomine Inc., Pohang, Korea
* Author for correspondence (e-mail: cho1988{at}yumc.yonsei.ac.kr)
Accepted 26 April 2007
 |
Summary |
|---|
 Top Summary IntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
Key words: p53, SiHa, H2O2, ROS, Oxidative stress, RNA interference (RNAi)
|
Introduction |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
) and therefore can indiscriminately oxidize biological molecules, providing a constant threat to cells in an oxygen-rich environment (Storz and Imlay, 1999). In living cells, endogenous ROS are generated as byproducts of cellular metabolism and through leakage of electrons from the mitochondrial electron transport chain (Nohle et al., 2003); they are also derived from exogenous sources such as UV radiation, 
-irradiation and chemicals. Present in all aerobic cells, ROS exist in a physiological balance with biochemical antioxidants. Oxidative stress occurs when this critical balance is disrupted, increasing intracellular ROS levels. To maintain intracellular redox homeostasis and protect against oxidative damage, cells have developed a sophisticated antioxidant defense system by enlisting functional antioxidant buffers through redox-coupled enzymatic networks that regenerate oxidized substrates (Martindale and Holbrook, 2002; Waris and Ahsan, 2006). In this system, superoxide dismutase (SOD) converts the superoxide anion radical (O2–) to H2O2, which is subsequently eliminated by catalase (CAT), glutathione peroxidase 1 (Gpx1) and peroxiredoxin (Prx). Gpx1 – a selenoprotein – is considered the primary enzyme responsible for the removal of H2O2 and may have a role in the regulation of cellular redox status (Burdon, 1995; de Hann et al., 1998). Likewise, Prx is a major reductant of endogenously produced peroxides in eukaryotes and catalyzes the conversion of H2O2 into H2O by using reducing equivalents provided by thioredoxin (Trx) (Rhee et al., 2001; Chae et al., 1994a; Chae et al., 1994b). During the peroxiredoxin catalytic cycle, peroxidatic cysteine is oxidized to a sulfenic acid form, which typically reacts with a proximal thiol to form a disulfide bond (Georgiou and Masip, 2003; Woo et al., 2003). This intermolecular disulfide bond is subsequently reduced by Trx; however, because the formation of the resolving disulfide bond is slow, high concentrations of ROS cause further oxidation of the peroxidatic cysteine to sulfinic acid, yielding an inactive form of Prx that cannot be reduced by typical cellular reductants such as glutathione or thioredoxin (Rabilloud et al., 2002; Wood et al., 2003; Yang et al., 2002). Sestrins are a family of cysteine sulfinyl reductases and are essential for reactivating Prx by reducing the cysteine sulfinic acid to thiol, thus reestablishing the antioxidant firewall (Budanov et al., 2004).
The tumor suppressor protein p53 is an important sensor of cellular stress and is involved in regulating cellular responses to DNA damage. Depending on the cell type and the context of stimuli, p53 can either induce cell growth arrest to allow repair or alternatively triggers apoptosis to prevent DNA damage in abnormal or stress-exposed cells from becoming fixed as a mutation (Lane, 1992). Additional evidence exists suggesting that p53 works in a more positive way, participating in the maintenance of intracellular redox homeostasis and protection of the genome from oxidative damage. First, there are several p53-regulated genes such as GPX1, SOD2 and aldehyde dehydrogenase 4 family member A1 (ALDH4A1), which encode products that act as antioxidants (Hussain et al., 2004; Tan et al., 1999; Yoon et al., 2004). Second, reactivation of overoxidized Prx is mediated by two p53-regulated sestrins, namely, PA26 and Hi95 (encoded by SESN1 and SESN2, respectively), which are required for regeneration of Prx containing cysteine sulfinic acid. Third, in the absence of stress or after mild stress, a relatively low level of p53 is sufficient to upregulate several antioxidant genes that decrease ROS levels and protect cells from DNA damage (Sablina et al., 2005).
Decreasing intracellular levels of ROS has long been a goal for cancer prevention. Owing to the effects of many cancer therapeutics, cancerous cells can be subjected to oxidative stress (Renschler, 2004), increasing the understanding of how ROS homeostasis is achieved in cancer cells, which may be crucial for the development of more effective cancer therapies. Cervical cancer is the second most common cancer among women in the world in both incidence and mortality, and high-risk human papillomavirus (HPV) – mainly serotypes 16 and 18 – is present in more than 90% of such tumors (Lazo, 1999; zur Hausen, 1996). Most HPV-positive cervical carcinoma cells possess the wild-type p53 gene, but it is often rendered non-functional by the E6 oncoprotein, which complexes with cellular proteins E6-AP and p53 to facilitate p53 degradation via a ubiquitin-dependent proteolytic system (Scheffner, 1998). When studied in cervical carcinoma cells expressing E6 in the context of its natural promoter, endogenous p53 protein could exert transcriptional function following DNA damage, despite coexpression of the viral E6 protein, suggesting that the amount of expressed HPV E6 is proportionate to the inhibition of p53 activity. Basal p53 activity, as measured with luciferase reporter assays in HPV-positive cervical cancer cells, showed that these cells have residual p53 activity and that p53 is not completely inactivated in cervical cancer cells (Butz et al., 1995; Butz et al., 1999; Hietanen et al., 2000).
To provide new insight into the possible role of endogenous p53 in the antioxidant defense of HPV-positive cervical cancer cells, we used a plasmid-mediated short hairpin RNA (shRNA) to knock down p53 expression in SiHa, HeLa, CaSki and ME180 cells (all of which integrated with high risk HPV sequences) and investigated whether p53 could modulate intracellular ROS levels under both nonstressed and stressed conditions. We found that endogenous p53 in SiHa cells was involved in the modulation of ROS levels, and may participate in maintaining ROS homeostasis. These findings might help to facilitate future clinical studies of HPV-positive cervical cancer therapy.
|
Results |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
|
|
|
) of SESN1 and a virtual disappearance of GPX1 and SESN2, whereas there were no differences in SOD1 and SOD2 expression after p53 knockdown in SiHa cells (Fig. 3B).
To show the effects of p53 on ROS levels in nonstressed cells, SiHa cells were labeled with the cell-permeable fluorescent dye CM-H2DCFDA, the fluorescence of which increases following oxidation by H2O2 and hydroxyl radicals in the cells. Fluorescent signals were analyzed by flow cytometry. CM-H2DCF staining indicated that there was an approximately twofold increase in ROS levels 24 hours after inhibition of p53, and the high levels of ROS remained for 72 hours (Fig. 4A,B), in agreement with the above observations that the expressions of GPX1, SESN1 and SESN2 were markedly decreased after p53 inhibition by siRNA. Next, we examined whether N-acetyl cysteine (NAC, a potent antioxidant) inhibits ROS accumulation in SiHa cells. As shown in Fig. 4C, the increase in ROS induced by p53-specific siRNA 48 hours after transfection was almost completely reversed by incubation with 5 mM NAC. To test whether p53 levels affect superoxide levels in SiHa cells, we employed DHE as a cytosolic superoxide indicator and MitoSOX RED as a mitochondrial superoxide indicator. Fluorescent intensities of both DHE and MitoSOX RED were not changed before and after p53 knockdown in SiHa cells (Fig. 4D,E), which was consistent with the observations that the expression of SOD1 and SOD2 were not affected by p53 deficiency in SiHa cells. When tested in cell culture, there was no notable change in the growth rate (Fig. 5A) or cell cycle distribution (Fig. 5B) of SiHa cells with inhibited p53, and addition of NAC (5 mM) did not affect cell proliferation. We also found the expression of p53-specific siRNA did not increase ROS levels in HeLa, CaSki and ME180 cell lines, similar to results with the negative control plasmid (Fig. 6).
|
|
|
p53 deficiency promotes intracellular ROS level in SiHa cells under oxidative stress
The results presented above suggest that p53 in the SiHa cell line may provide a protective function by participating in antioxidant defense. To test the role of p53 in antioxidant defense according to the severity of oxidative stress, we compared ROS levels in control and p53-deficient SiHa cells stimulated with different concentrations of H2O2. 48 hours after transfection with either the negative control plasmid (SiHa/N) or p53 shRNA plasmid (SiHa/sip53), cells were mock treated or treated with different concentrations of H2O2 for 12 hours and intracellular levels of ROS were analyzed. Compared with SiHa/N cells with negative siRNA, both untreated and H2O2-treated SiHa/sip53 cells (in which p53 was inhibited by siRNA) exhibited markedly increased ROS levels. Intriguingly, we also observed that even at a lethal dose of H2O2 (1 mM), ROS level in SiHa/sip53 cells was much higher than that in SiHa/N cells (Fig. 7). Taken together, the data strongly suggest that endogenous p53 in HPV-positive SiHa cells functions as an antioxidant and may play an important role following oxidative stress.
|
|
p53 deficiency increases DNA oxidation in SiHa cells
To determine whether p53 is required for the protection of DNA from oxidative damage, we monitored the rate of formation of 8-oxoguanine (8-oxo-dG), the major product of DNA oxidation, using an assay kit as described in the Materials and Methods. SiHa cells with siRNA-inhibited p53 displayed a twofold increase in levels of 8-oxo-dG compared with control cells (Fig. 9A). We also examined whether p53 is associated with oxidative DNA damage induced by challenge with H2O2, and evaluated the possible role of p53 in the removal of such DNA damage in SiHa cells. Treatment of cells with 0.1 and 0.5 mM H2O2 for 1 hour resulted in an increase in 8-oxo-dG levels, as indicated by the increase in fluorescence of the 8-oxo-dG signal. However, there was a significant difference in the levels of 8-oxo-dG in SiHa/N and SiHa/sip53 cells. SiHa/sip53 cells consistently exhibited higher 8-oxo-dG content than SiHa/N cells (Fig. 9B). Therefore, these data suggest that in the SiHa cell line, p53 may participate in protecting DNA from oxidative damage.
|
p53 facilitates the removal of 8-oxo-dG residues from DNA in whole SiHa cells
Finally, we performed pulse-chase experiments to test whether p53 facilitates the removal of 8-oxoG residues from DNA in the SiHa cell line. 48 hours after transfection with negative control plasmid or p53 shRNA plasmid, cells were treated with 0.5 mM H2O2 for 1 hour to induce 8-oxo-dG accumulation. After treatment, the medium was changed and the cells were incubated without H2O2 for various times. To evaluate the rate of 8-oxo-dG elimination, the level of 8-oxo-dG remaining was detected at each time point. SiHa/sip53 cells were slower than SiHa/N cells to remove 8-oxo-dG from the DNA, with the time for the level of 8-oxo-dG to decrease by 50% (t1/2) was 3.1 hours and more than 6 hours, respectively (Fig. 10).
|
|
Discussion |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
). The oncogenic activity of high-risk HPVs is explained in part by the ability of the viral E6 oncoprotein to target p53 for degradation and thus to inhibit p53-mediated transcription (Hoppe-Seyler and Butz, 1993). However, studies investigating the functional status of p53 in a series of HPV-positive cancer cells expressing the E6 gene from chromosomally integrated viral sequences under its natural promoter have produced differing results, indicating that despite co-expression of the viral E6 oncogene, there is residual p53 activity, indicating that endogenous p53 is not completely inactivated in HPV-positive cancer cells (Abdulkarim et al., 2002; Butz et al., 1995; Butz et al., 1999; Hengstermann et al., 2001; Hietanen et al., 2000). To date, there are no suitable anti-E6 antibodies available for reliable quantification, and thus the presence of viral E6 protein has not been unambiguously demonstrated in HPV-positive cancers. Therefore, it is currently widely assumed that E6 protein levels are very low in HPV-positive carcinoma cell lines and might be limited in their capacity to interfere with p53 function. In the present study, we found that endogenous p53 in SiHa cells is involved in the modulation of intracellular ROS levels, participates in maintaining ROS homeostasis in response to oxidative stress and protects DNA against oxidative damage.
Direct comparison of p53 protein levels between HPV-positive cervical carcinoma cell lines, as examined by immunoblot analysis, indicated that SiHa cells had the highest steady-state level of p53. This result is in full agreement with previous findings Scheffner et al. (Scheffner et al., 1991) who showed that p53 level in SiHa cells is 3-5 times higher than that in other HPV-positive cervical cancer cells. A recent study (Sablina et al., 2005) provided evidence that even the very low levels of p53 present in normal tissues in the absence of stress are sufficient enough to drive the expression of several antioxidant genes. Therefore, we next addressed the hypothesis that high levels of p53 in SiHa cells may contribute to some antioxidant enzymes. Indeed, among the series of HPV-positive cancer cell lines investigated in this study, SiHa cells exhibited the highest expression of GPX1, SESN1 and SESN2, implying that SiHa cells may have a powerful antioxidant defense system and are thus tolerant of severe oxidative insults. By using H2O2 to induce oxidative stress, we found that HeLa, CaSki and ME180 cells were severely impaired in their antioxidant capacity, whereas SiHa cells, as expected, exhibited a higher resistance to H2O2 damage. Given the evidence that p53 is a major regulator of the H2O2 response in human cells (Desaint et al., 2004), the above findings raised the question whether the presence of a high steady-state level of p53 in SiHa cells has an antioxidant function.
Expression of p53 was knocked down by transfecting U6 promoter-driven shRNA constructs into SiHa cells. We were able to demonstrate that p53 was reduced 24-72 hours post transfection, compared with that in the control. Likewise, the levels of GAPDH protein and ACTB (encoded 
-actin) mRNA remained unchanged, indicating that the reduction of p53 was specific. Interestingly, we also noted that the expression of GPX1, SESN1 and SESN2 were also inhibited following p53 RNAi in SiHa cells. These observations further supported the idea that p53 is transcriptionally competent despite co-expression of the viral E6 protein and could induce antioxidant gene expressions in SiHa cells in the absence of stress. Elevated levels of ROS were also found in p53-deficient SiHa cells, although this could be reversed by NAC supplementation. These data strengthened the idea that the antioxidant function of p53 is mediated through a set of antioxidant gene products, and the depletion/downregulation of p53 damped down the antioxidant defense in SiHa cells.
Intriguingly, although p53 deficieny promoted ROS levels in SiHa cells, we did not observe a similar correlation between p53 protein and ROS levels in the other three HPV-positive cervical cancer cells HeLa, CaSki and ME180. Different scenarios could be envisaged to explain the differences in the modulation of ROS by p53 in the HPV-positive cancer cells investigated in the present study. The transcriptional activity of p53 to activate antioxidant genes is necessarily correlated with p53 protein abundance, and a steady-state level of p53 may be required for its transcriptional activity in HPV-positive cells under physiological conditions. Consistent with this notion, the p53 levels in HeLa, CaSki and ME180 cells were much lower than that in normal HFK cells. It has been reported that p53 levels detected in HeLa, CaSki and ME180 cells ranged from 0.4- to 0.6-times that found in secondary cultures of HFKs (Scheffner et al., 1991). Furthermore, the levels of p53-regulated antioxidant enzymes, GPX1, SESN1 and SESN2, were very low, and even undetectable in the three cell lines. In addition, there may also be cell-specific differences in the regulation of cellular antioxidant abilities between these cell lines. It will also be interesting to study the role of HPV in the differential response of these HPV-positive cell lines to oxidative stress because these cell lines harbor different subtypes and copies of HPV.
In concordance with the notion that the p53 protein is functional in SiHa cells, we observed a much higher level of ROS in p53-deficient SiHa cells following H2O2 exposure than in SiHa cells containing wild-type p53. Indeed, it has been shown previously that p53 induces ROS accumulation and a number of genes induced by p53 are associated with the metabolism of ROS (Macip et al., 2003; Polyak et al., 1997). Understanding how p53 stimulates the accumulation of ROS level is complicated by the opposite finding that p53 also regulates the expression of antioxidant enzymes. The study from by Sablina et al. extended such observations that (1) in the absence of stress or after mild stress, p53 induces the expression of antioxidant genes that decrease ROS levels and protect cells from DNA damage; (2) severe or extended stress leads to stronger activation of p53, and thus induces the pro-oxidant genes, results in elevated ROS levels and cell death (Sablina et al., 2005; Bensaad and Vousden, 2005). In the present study, the p53-deficient cells showed a higher ROS level than control cells did, even at lethal concentrations of H2O2 (1 mM). These findings were in contrast with a previous study (Sablina et al., 2005) in which p53 showed pro-oxidant activity and thus promoted ROS levels in HPV-negative cell types under severe oxidative damage. One possible explanation may be that the antioxidant and pro-oxidant function of p53 was temporally separated (Bensaad and Vousden, 2005; Sengupta and Harris, 2005) and the pro-oxidant function of p53 is severely impaired in SiHa cells.
Furthermore, cells containing reduced p53 were more susceptible to H2O2-induced cell death. As shown in this study, a more rapid and greater magnitude of cell death was observed in SiHa cells with p53 deficiency after H2O2-challenge, indicating that the antioxidant defense of the SiHa cell line was achieved, at least in part, by endogenous p53, and therefore depletion of p53 followed by inhibition of the expression of some antioxidant enzymes disintegrated the antioxidant firewall and sensitized cells to oxidative stress.
The p53 tumor suppressor, a `guardian of the genome', restricts abnormal or stress-exposed cells before DNA damage becomes fixed as a mutation (Lane, 1992). A key target of ROS in cells is the DNA, and under physiological conditions the endogenous ROS that are byproducts of normal respiration modify approximately 20,000 bases of DNA per day in a single cell (Beckman and Ames, 1997; Droge, 2002; Finkel, 2003). Thus, endogenous ROS are a major source of DNA damage and a substantial factor contributing to chromosomal instability, accumulation of mutations (Jackson and Loeb, 2001; Klungland et al., 1999) and deletions that may lead to cancer (Griffiths et al., 1997; Havre et al., 1995). A frequent oxidative modification of DNA is the hydroxylation of guanine at C-8, leading to the formation of 8-oxo-dG) (Breen and Murphy, 1995; Wiseman and Halliwell, 1996). In the present study, we showed that p53 protein in the SiHa cell line has a protective role against DNA oxidation. SiHa cells deficient in p53 displayed significantly increased 8-oxo-dG levels under both non-stressed and oxidative stressed conditions, a finding that was consistent with the observation that 8-oxo-dG residues were removed more rapidly from cellular DNA in whole SiHa cells with wild-type p53. Together, these results suggested that the endogenous p53 in the SiHa cell line plays a role in protecting DNA and facilitating cellular responses to ROS-induced DNA damage.
In conclusion, we have provided evidence that endogenous p53 in SiHa cells has an antioxidant function and is involved in the reinforcement of the antioxidant defense. Depletion of p53 by RNAi in the SiHa cell line resulted in disintegration of the antioxidant firewall and increased oxidative damage. As ROS are also involved in cancer chemoradiotherapy, these findings may help to facilitate clinical studies of HPV-positive cervical cancer therapy.
|
Materials and Methods |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
Western blot analysis
Cell lysates were made using the PRO-PREP protein extraction solution (Intron Biotech, Korea). Lysates were clarified by centrifugation at 15,000 g at 4°C for 20 minutes and the protein concentration of the supernatant was determined with a Bradford assay (BioRad). For SDS-PAGE protein lysates were mixed with Laemmli sample buffer and boiled for 20 minutes. Total protein was separated on a 12% gel and transferred to nitrocellulose (Amersham, Germany). After blocking in TBST (20 mM Tris-HCl, 137 mM NaCl, 0.1% Tween 20, pH 7.6) with 5% skimmed milk, membranes were incubated with the primary antibodies diluted in TBST with 3% skimmed milk for 2 hours at room temperature. Next, membranes were washed three times with TBST, and incubated for an additional 2 hours with horseradish peroxidase-linked secondary antibody (1:2000) diluted in TBST with 3% skimmed milk. Labeled protein bands were visualized with the enhanced chemiluminescence reagent (ECL) (Pierce, Rockford). Mouse monoclonal DO1 antibody against p53 (1:2000), goat polyclonal antibody against SOD2 (1:200), rabbit polyclonal antibody against SOD1 (1:200) and goat polyclonal antibody against GAPDH (1:2000) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal antibody against GPX1 (2 µg/ml) was obtained from MBL (Japan). Rabbit polyclonal antibody against SESN2 (1:1000) was purchased from Proteintech (Chicago, IL). Horseradish peroxidase-labeled secondary antibodies were purchased from Zymed. Immunoblotting for GAPDH was performed to verify equivalent protein loading. Densitometry analysis of western blots was performed using TINA 2.0 Software (Raytest Isotopenmessgerate Gmbh, Straubenhardt, Germany).
RNA isolation and RT-PCR analysis
Cells were collected and total RNA was extracted using an UltraspecTM-II RNA isolation kit (Biotecx, Houston, TX). To prepare cDNA, 500 ng total RNA was mixed with the SuperScript RT-PCR System (Invitrogen). 5 µl of the RT reaction was then used for PCR using the HotStarTaq DNA polymerase (Qiagen). The PCR reactions were carried out under the following temperature profile: (1) denaturation at 95°C for 15 minutes; (2) 35 cycles of 95°C for 40 seconds, 56°C for 1 minute, 72°C for 1 minute; (3) a final extension for 10 minutes at 72°C. To detect the corresponding gene expression, we used the following primers: TP53, 5'-TCCACTACAACTACATGTGTAAC-3' and 5'-GTGAAATATTCTCCATCCAGTG-3'; SESN1 (T2), 5'-CGACCAGGACGAGGAACTT-3' and 5'-CCAATGTAGTGACGATAATGTAGG-3' ACTB, 5'-AAGAGAGGCATCCTCACCCT-3' and 5'-TACATGGCTGGGGTGTTGAA-3'.
RNA interference
To generate a short hairpin RNA specific for p53, we used the pSuppressorNeo p53 plasmid (IMG-803, Imgenex, San Diego, CA). A negative control plasmid (IMG-800) with a scrambled sequence was supplied by Imegenex. The following sequences, representing 19 bp of the mRNAs, were present in the hairpin transcripts: TP53, 5'-GACTCCAGTGGTAATCTAC-3'; negative control, 5'-AGTCACGTTAATGGTCGTT-3'. Cells were cultured overnight and transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the protocol of the manufacturer. Briefly, both the DNA and Lipofectamine 2000 were diluted with serum-free medium. The diluted DNA was added to the diluted Lipofectamine 2000, mixed gently, and incubated at room temperature for 30 minutes. Lastly, the DNA-Lipofectamine 2000 mixture was carefully added to cells at 95% confluency in fresh medium without antibiotics and incubated at 37°C.
Cell proliferation and viability analysis
To measure the number of viable cells, a Trypan Blue exclusion assay was used. Cells were seeded in a 24-well plate and incubated for 24 hours. At the indicated time points, cells were collected and stained with 0.2% Trypan Blue. Cell numbers were determined by direct counting of cells under the microscope, using a standard haemocytometer. Cell viability was measured using a WelCountTM Cell Viability Assay Kit (WelGENE, Seoul, Korea). Briefly, we defrosted the XTT reagent and PMS at 37°C, prepared the reaction mixture (40 µl PMS and 2 ml XTT reagent per plate), added 20 µl of the reaction mixture to each well (each containing 100 µl media) and incubated at 37°C for 4 hours. After observing a change in color of the solution, we measured these samples at a wavelength of 490 nm using a Molecular Devices VERSAmax microplate reader (Molecular Devices, Sunnyvale, CA). All experiments were performed in triplicate.
Measurement of ROS accumulation
Intracellular production of ROS was measured using cell-permeable fluorescent dyes, 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA, Molecular Probes), dihydroethidium (DHE, Molecular Probes) and MitoSOX RED (Molecular Probes). When these dyes are oxidized by ROS in cells, their fluorescent signals increase. CM-H2DCFDA is mainly oxidized by hydrogen peroxide (H2O2) and hydroxyl radicals, DHE is oxidized by cytosolic superoxide anion, whereas MitoSOX RED is selectively oxidized by superoxide anion in the mitochondria. For the assay, cells were plated in six-well plates and loaded with CM-H2DCFDA or DHE for 30 minutes, or MitoSOX RED for 10 minutes in the dark at 37°C. Next, cells were washed twice with PBS, trypsinized and fluorescence was measured using flow cytometry (excitation at 488 nm, emission at 515–545 nm). Data analysis was performed with CELLQuest software and the mean fluorescence intensity was used to quantify the responses. A minimum of 10,000 cells was acquired for each sample.
Cell cycle distribution observation
Flow cytometry analysis of PI-stained cells was performed to demonstrate the progression of the cell cycle. Briefly, cells were harvested, washed and fixed in 70% ethanol overnight at 4°C. Prior to flow cytometry, cells were washed and stained with 1 ml PI (5 µg/ml) containing 0.1 mg/ml RNaseA. DNA content was determined with a FACScan flow cytometer (Becton Dickinson) and the proportion of cells in a particular phase of cell cycle was determined with CellQuest software.
Apoptosis assay by Annexin V/PI staining
An Annexin V-FITC Apoptosis Kit I (BD, San Jose, CA, USA) was used to detect apoptosis. Annexin V is a Ca2+-dependent phospholipid-binding protein that has a high affinity for phosphatidylserine (PS). In apoptotic cells, PS is translocated from the inner leaflet of the plasma membrane to the outer leaflet. Propidium iodide (PI), a standard flow cytometric viability probe, was used to distinguish between viable and nonviable cells. Cells that were stained were detected by a flow cytometer. Briefly, 1x106 cells were harvested, washed with ice-cold PBS, and resuspended in 500 µl of Annexin binding buffer. A 100 µl aliquot (2x105 cells) was taken, 5 µl each of Annexin V-FITC and PI were added and cells were incubated for 15 minutes at room temperature in the dark. 400 µl binding buffer (10 mM HEPES-NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) was added and samples were acquired on a FACScan flow cytometer (FACSCalibur, Becton Dickinson) and analyzed using CELLQuest software with in 1 hour. Cells that were Annexin V–/PI+ were counted as necrotic, those that showed up as Annexin V+/PI+ were counted as late apoptotic or secondarily necrotic, and Annexin V+/PI– cells were recognized as apoptotic. All procedures stated above were performed according to the manufacturer's instructions.
Detection of 8-oxo-dG residues in DNA
After transfection with the pSuppressorNeo p53 or negative control plasmids for 48 hours, cells were treated with H2O2 at concentrations of 0.1 mM and 0.5 mM for 1 hour. The levels of 8-oxo-dG residues in cellular DNA before and following treatment with H2O2 were determined using the OxyDNA assay kit (EMD Biosciences, San Diego, CA). This assay is based upon the direct binding of a fluorescent probe to 8-oxoguanine in the DNA of fixed cells (Achanta and Huang, 2004; Struthers et al., 1998). Cells were harvested, washed with PBS, and fixed with 2% paraformaldehyde on ice for 15 minutes. The samples then were washed with PBS and fixed in 70% ethanol at –20°C overnight. The following day, the cells were washed once with PBS, followed by the wash solution provided by the manufacturer. Next, the cells were incubated with blocking solution, and then treated with the 8-oxo-dG-specific FITC-labeled probe and analyzed by flow cytometry according to the manufacturer's protocol. The intensity of the FITC fluorescent signal was proportional to the level of 8-oxoG residues in DNA.
Analysis of 8-oxo-dG residue removal from DNA
A pulse-chase experiment was used to assay the removal of 8-oxo-dG residues from DNA in whole cells. First, cells were transfected with pSuppressorNeo p53 or negative control plasmids for 48 hours. Following the transfection, cells were treated with 0.5 mM H2O2 for 1 hour. Afterwards, cells were rinsed with fresh medium (without H2O2) incubated. Cells were harvested before or at various times after incubation in fresh medium. Relative abundance of 8-oxo-dG in cellular DNA was measured as described previously. The decrease of 8-oxoG signal as a function of the chase time was taken as 8-oxoG removal from DNA in whole cells.
Statistical analysis
The Student's t-test was used for statistical analysis. Statistical significance was accepted if the null hypothesis was rejected with P<0.05.
|
Acknowledgments |
|---|
|
References |
|---|
|
TopSummaryIntroductionResultsDiscussionMaterials and MethodsReferences |
|---|
Abdulkarim, B., Sabri, S., Deutsch, E., Chagraoui, H., Maggiorella, L., Thierry, J., Eschwege, F., Vainchenker, W., Chouaib, S. and Bourhis, J. (2002). Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers. Oncogene 21, 2334-2346.[CrossRef][Medline]
Achanta, G. and Huang, P. (2004). Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res. 64, 6233-6239.
Beckman, K. B. and Ames, B. N. (1997). Oxidative decay of DNA. J. Biol. Chem. 272, 19633-19636.
Bensaad, K. and Vousden, K. H. (2005). Savior and slayer: the two faces of p53. Nat. Med. 11, 1278-1279.[CrossRef][Medline]
Breen, A. P. and Murphy, J. A. (1995). Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18, 1033-1077.[CrossRef][Medline]
Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V. and Chumakov, P. M. (2004). Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600.
Burdon, R. (1995). Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18, 775-794.[CrossRef][Medline]
Butz, K., Shahabeddin, L., Geisen, C., Spitkovsky, D., Ullmann, A. and Hoppe-Seyler, F. (1995). Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10, 927-936.[Medline]
Butz, K., Whitaker, N., Denk, C., Ullmann, A., Geisen, C. and Hoppe-Seyler, F. (1999). Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 18, 2381-2386.[CrossRef][Medline]
Chae, H. Z., Chung, S. J. and Rhee, S. G. (1994a). Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269, 27670-27678.
Chae, H. Z., Uhm, T. B. and Rhee, S. G. (1994b). Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad. Sci. USA 91, 7022-7026.
de Hann, J. B., Bladier, C., Griffiths, P., Kelner, M., O'Shea, R. D., Cheung, N. S., Bronson, R. T., Silvestro, M. J., Wild, S., Zheng, S. S. et al. (1998). Mice with homozygous null mutation for the most abundant glutathione peroxidase, GPX1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J. Biol. Chem. 273, 22528-22536.
Desaint, S., Luriau, S., Aude, J. C., Rousselet, G. and Toledano, M. B. (2004). Mammalian antioxidant defenses are not inducible by H2O2. J. Biol. Chem. 279, 31157-31163.
Droge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
Finkel, T. (2003). Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254.[CrossRef][Medline]
Georgiou, G. and Masip, L. (2003). An overoxidation journey with a return ticket. Science 300, 592-594.
Griffiths, S. D., Clarke, A. R., Healy, L. E., Ross, G., Ford, A. M., Hooper, M. L., Wyllie, A. H. and Greaves, M. (1997). Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene 14, 523-531.[CrossRef][Medline]
Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R. and Glazer, P. M. (1995). p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res. 55, 4420-4424.
Hengstermann, A., Linares, L. K., Ciechanover, A., Whitaker, N. J. and Scheffner, M. (2001). Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA 98, 1218-1223.
Hietanen, S., Lain, S., Krausz, E., Blattner, C. and Lane, D. P. (2000). Activation of p53 in cervical carcinoma cells by small molecules. Proc. Natl. Acad. Sci. USA 97, 8501-8506.
Hoppe-Seyler, F. and Butz, K. (1993). Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol. 67, 3111-3117.
Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okamura, S. et al. (2004). p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 64, 2350-2356.
Jackson, A. L. and Loeb, L. A. (2001). The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res. 477, 7-21.[Medline]
Jeon, S., Allen-Hoffmann, B. L. and Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69, 2989-2997.[Abstract]
Klungland, A., Rosewell, I., Hollenbach, S., Larsen, E., Daly, G., Epe, B., Seeberg, E., Lindahl, T. and Barnes, D. E. (1999). Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA 96, 13300-13305.
Lane, D. P. (1992). p53, guardian of the genome. Nature 358, 15-16.[CrossRef][Medline]
Lazo, P. A. (1999). The molecular genetics of cervical carcinoma. Br. J. Cancer 80, 2008-2018.[CrossRef][Medline]
Macip, S., Igarashi, M., Berggren, P., Yu, J., Lee, S. W. and Aaronson, S. A. (2003). Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23, 8576-8585.
Martindale, J. L. and Holbrook, N. J. (2002). Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15.[CrossRef][Medline]
Nohl, H., Kozlov, A. V., Gille, L. and Staniek, K. (2003). Cell respiration and formation of reactive oxygen species: facts and artifacts. Biochem. Soc. Trans. 31, 1308-1311.[Medline]
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. and Vogelstein, B. (1997). A model for p53-induced apoptosis. Nature 389, 300-305.[CrossRef][Medline]
Rabilloud, T., Heller, M., Gasnier, F., Luche, S., Rey, C., Aebersold, R., Benahmed, M., Louisot, P. and Lunardi, J. (2002). Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277, 19396-19401.
Renschler, M. F. (2004). The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer 40, 1934-1940.[CrossRef][Medline]
Rhee, S. G., Kang, S. W., Chang, T. S., Jeong, W. and Kim, K. (2001). Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52, 35-41.[Medline]
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E. and Chumakov, P. M. (2005). The antioxidant function of the p53 tumor suppressor. Nat. Med. 11, 1306-1313.[CrossRef][Medline]
Scheffner, M. (1998). Ubiquitin, E6-AP, and their role in p53 inactivation. Pharmacol. Ther. 78, 129-139.[CrossRef][Medline]
Scheffner, M., Munger, K., Byrne, J. C. and Howley, P. M. (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88, 5523-5527.
Sengupta, S. and Harris, C. C. (2005). p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6, 44-55.[CrossRef][Medline]
Storz, G. and Imlay, J. A. (1999). Oxidative stress. Curr. Opin. Microbiol. 2, 188-194.[CrossRef][Medline]
Struthers, L., Patel, R., Clark, J. and Thomas, S. (1998). Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal. Biochem. 255, 20-31.[CrossRef][Medline]
Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W. and Sun, Y. (1999). Transcriptional activation of the human glutathione peroxidase promoter by p53. J. Biol. Chem. 274, 12061-12066.
Thannickal, V. J. and Fanburg, B. L. (2000). Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1005-L1028.
Waris, G. and Ahsan, H. (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog. 5, 14.[CrossRef][Medline]
Wiseman, H. and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313, 17-29.[Medline]
Woo, H. A., Chae, H. Z., Hwang, S. C., Yang, K. S., Kang, S. W., Kim, K. and Rhee, S. G. (2003). Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300, 653-656.
Wood, Z. A., Poole, L. B. and Karplus, P. A. (2003). Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300, 650-653.
Yang, K. S., Kang, S. W., Woo, H. A., Hwang, S. C., Chae, H. Z., Kim, K. and Rhee, S. G. (2002). Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277, 38029-38036.
Yoon, K. A., Nakamura, Y. and Arakawa, H. (2004). Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J. Hum. Genet. 49, 134-140.[CrossRef][Medline]
zur Hausen, H. (1996). Papillomavirus infections–a major cause of human cancers. Biochim. Biophys. Acta 1288, F55-F78.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
